Register your Account

Sign Up with us and Enjoy!
User name Email First Name Last Name Contact info

A password will be e-mailed to you.

Notable Winners (PPC, CLSN, IVAN, MELA, INO)


Houston, TX – January 15, 2013 – (MESHPRESS) – Holeinonestocks.net, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:-

Pilgrim’s Pride Corporation (NASDAQ:PPC) shares jumped 7.06% and closed at $8.64. A female Pilgrim’s Pride employee has filed a gender discrimination suit claiming that she was falsely terminated when a welding machine went missing but no male employees were terminated. Amy Greer filed suit against Pilgrim’s Pride Corp. on Jan. 11 in the Eastern District of Texas, Marshall Division.

Additionally, the company, on Dec. 17, announced that it will voluntarily transfer its stock exchange listing from The New York Stock Exchange to The NASDAQ Global Select Market, an exchange of The NASDAQ OMX Group Inc. The Company currently expects that its common stock will commence trading on the NASDAQ on December 28, 2012 and will continue to be listed under the ticker symbol “PPC.”

Is PPC Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here

Celsion Corporation (NASDAQ:CLSN) shares climbed 6.97% to $9.05 in the previous trading session. The company is very close to its top-line release of its Phase III study, called the HEAT trial, designed to show that ThermoDox + RFA treatment improves the time to progression of HCC liver cancer by at least 33% for patients with large tumors versus RFA alone.

How Should Investors Trade CLSN After The Recent Volatile Moves? Find Out Here

Ivanhoe Energy Inc. (USA) (NASDAQ:IVAN) shares increased 6.89% and closed at $0.791. The company, last month, announced that through its wholly-owned subsidiary Sunwing Zitong Energy (Sunwing), it has completed the previously announced transfer of the Company’s participating interest in the Contract for Exploration, Development and Production in the Zitong Block (Petroleum Contract) to Shell China Exploration and Production Co. (Shell).

How Should Investors Trade IVAN After The Recent Volatile Moves? Find Out Here

MELA Sciences, Inc. (NASDAQ:MELA) shares gained 6.88% to $2.02. The company announced that it will be participating in the upcoming Needham Growth Conference, being held January 15 – 17, 2013 at the Palace Hotel in New York. Joseph V. Gulfo, MD, MELA Sciences President and CEO will be presenting at the conference on Wednesday, January 16 at 10:00am ET.

Is MELA Ready To Move Back To New Highs This Year? Find Out Here

Inovio Pharmaceuticals, Inc. (NYSEAMEX:INO) shares increased 6.67% to $0.640 in the last trading session. The PATH Malaria Vaccine Initiative (MVI) and INO, last week, announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies. Researchers will test whether a novel vaccine approach that combines genetically engineered DNA with an innovative vaccine delivery technology called electroporation could induce an immune response in humans that protects against malaria parasite infection.

Is INO Ready To Move Back To New Highs This Year? Find Out Here

About Holeinonestocks.net

Holeinonestocks team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Holeinonestocks’ instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Holeinonestocks.

Disclaimer:

The assembled information disseminated by Holeinonestocks is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Holeinonestocks does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:

Holeinonestocks.net

staff@Holeinonestocks.net

 

Related Press realease: